SARAH GIERHAN: Open Payments
NPI 1790224996 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 81 payments from 12 companies in 2025. Trend: 2023 $1,130 · 2024 $3,071 · 2025 $1,272
Food & beverage: $1,272
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $349 |
| Otsuka America Pharmaceutical, Inc. | 15 | $280 |
| Alkermes, Inc. | 13 | $229 |
| Axsome Therapeutics, Inc. | 5 | $136 |
| Collegium Pharmaceutical, Inc. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Lundbeck LLC | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: VRAYLAR, ARISTADA, REXULTI, Auvelity, ABILIFY MAINTENA, Jornay PM, CAPLYTA, Qelbree.
Industry payments across NE — which companies pay providers there.
